bpc-157 news just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank BPC-157 vs. TB-500: Comparing Two

The FDA also notes that no safety-related information regarding DSIP has been identified, so its unknown whether it could be harmful to humans.26 Given these conclusions, we shouldnt be surprised that DSIP is not an FDA-approved peptide therapy

The hype is enormous -- which is exactly why I want to give you a clear-eyed, physician's take on what we actually know, what we don't, and what a responsible approach to this peptide looks like

As rates rose again from 2022 onward, NII rebounded sharply, driven by asset repricing, robust loan demand and disciplined funding management.

Peptide safety varies considerably

Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of MTC or with MEN2

For researchers looking at broader peptide stacking strategies, the peptide stack calculator helps determine compatible combinations